PRM trades 35.1% below Wall Street's consensus target of $39.00.
Last 12 months price action with 12-month analyst target path
The base valuation assumes PRM achieves its forward estimates and maintains a stable P/E multiple of 18.5x. This scenario reflects the blended consensus of 3 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of November 18, 2026, Perimeter Solutions, Inc. (PRM) has a Wall Street consensus price target of $39.00, based on estimates from 3 covering analysts. With the stock currently trading at $28.86, this represents a potential upside of +35.1%. The company has a market capitalization of $4.71B.
Analyst price targets range from a low of $38.00 to a high of $40.00, representing a 5% spread in expectations. The median target of $39.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 3 analysts rating the stock as a Buy or Strong Buy,0 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, PRM trades at a trailing P/E of 90.9x and forward P/E of 18.5x. Analysts expect EPS to grow +392.5% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $10.24, with bear and bull scenarios of $6.45 and $13.49 respectively. Model confidence stands at 45/100, suggesting limited visibility into future performance.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
IOSPInnospec Inc. | $1.9B | $78.01 | $110.00 | +41.0% | Hold | 15.8x | 9 |
ASIXAdvanSix Inc. | $398M | $14.78 | $30.80 | +108.4% | Buy | 79.9x | 7 |
KWRQuaker Houghton | $2.6B | $151.08 | $186.33 | +23.3% | Buy | 18.9x | 16 |
BCPCBalchem Corp | $5.5B | $169.63 | $212.50 | +25.3% | Buy | 31.0x | 10 |
ALBAlbemarle Corporation | $10.3B | $87.67 | $167.09 | +90.6% | Buy | 8.0x | 46 |
AVNTAvient Corporation | $4.0B | $43.54 | $47.00 | +7.9% | Buy | 13.5x | 22 |
FULH.B. Fuller Company | $2.6B | $47.79 | $62.33 | +30.4% | Buy | 9.9x | 15 |
CBTCabot Corp. | $3.6B | $70.14 | $94.00 | +34.0% | Buy | 11.0x | 16 |
TROXTronox Holdings plc | $306M | $1.92 | $5.86 | +205.2% | Hold | — | 17 |
PRLBProto Labs, Inc. | $1.5B | $64.29 | $110.00 | +71.1% | Hold | 28.4x | 17 |
Quick answers to the most common questions about buying PRM stock.
The consensus Wall Street price target for PRM is $39, representing 35.1% upside from the current price of $28.86. With 3 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
PRM has a consensus rating of "Buy" based on 3 Wall Street analysts. The rating breakdown is predominantly bullish, with 3 Buy/Strong Buy ratings. The consensus 12-month price target of $39 implies 35.1% upside from current levels.
With a forward P/E of 18.4621x, PRM trades at a relatively low valuation. The consensus target of $39 implies 35.1% appreciation, suggesting meaningful undervaluation.
The most bullish Wall Street analyst has a price target of $40 for PRM, while the most conservative target is $38. The consensus of $39 represents the median expectation. Our quantitative valuation model projects a bull case target of $13 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
PRM is lightly followed, with 3 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 3 have Buy ratings, 0 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month PRM stock forecast based on 3 Wall Street analysts shows a consensus price target of $39, with estimates ranging from $38 (bear case) to $40 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $10, with bear/bull scenarios of $6/$13.
Our quantitative valuation model calculates PRM's fair value at $10 (base case), with a bear case of $6 and bull case of $13. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 45/100.
PRM trades at a forward P/E ratio of 18.5x based on next-twelve-months earnings estimates compared to a trailing P/E of 90.9x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are very optimistic on PRM, with a "Buy" consensus rating and $39 price target (35.1% upside). 3 of 3 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
PRM analyst price targets range from $38 to $40, a 5% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $39 consensus represents the middle ground. Our model's $6-$13 range provides an independent fundamental perspective.
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.